WES analysis of this tumor and matching blood revealed amplification of chromosome 7 and deletion of chromosome 10, together with focal deletion of the cyclin-dependent kinase inhibitor 2A (CDKN2A) locus on chromosome 9. Here, CDKN2A is linked to neoplasm.